Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Impact of SugarLock® Peanut Skin Extract on Postprandial Blood Glucose Control

NCT07705191 is registered in ClinicalTrials.gov with TCI Co., Ltd. as lead sponsor.

NCT NCT07705191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07705191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Impact of SugarLock® Peanut Skin Extract on Postprandial Blood Glucose Control
Lead sponsor
TCI Co., Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
July 9, 2026
Completion date
October 31, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood sugar (glucose) control, postprandial glucose